Indeed, high-grade glioma TMAs immunostaining for ZEB1 revealed abundant expression of this protein (Figure 6A), as well as a positive correlation between ZEB1 and serglycin levels (ρ < 0.01, Figure 6B). Here, SRGN is linked to central nervous system cancer.